fig6
Figure 6. Psammaplin C, a natural product CA XII inhibitor that has been used in preclinical studies of glioblastoma in combination with Pgp substrate chemotherapeutics. CA: carbonic anhydrase; Pgp: p-glycoprotein.
Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Navigation
Committee on Publication Ethics
https://publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/
Follow OAE
